| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 0 | 27.607 | 93.642 | 125.464 | 150.196 | 213.684 | 268.319 | 312.294 | 357.876 |
| Total Income - EUR | - | 0 | 28.921 | 95.556 | 127.726 | 152.450 | 215.779 | 270.176 | 314.754 | 362.302 |
| Total Expenses - EUR | - | 5.833 | 42.908 | 90.440 | 119.792 | 134.805 | 184.400 | 211.919 | 255.573 | 319.668 |
| Gross Profit/Loss - EUR | - | -5.833 | -13.987 | 5.116 | 7.934 | 17.645 | 31.379 | 58.257 | 59.181 | 42.634 |
| Net Profit/Loss - EUR | - | -5.833 | -14.267 | 4.177 | 6.672 | 16.236 | 29.492 | 55.958 | 56.166 | 32.862 |
| Employees | - | 2 | 3 | 2 | 2 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Pharma Oas S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 8.630 | 4.975 | 1.692 | 907 | 618 | 6.160 | 20.480 | 17.884 |
| Current Assets | - | 11.176 | 18.922 | 20.584 | 26.629 | 37.813 | 47.182 | 98.721 | 147.270 | 189.678 |
| Inventories | - | 663 | 13.256 | 12.220 | 14.915 | 24.537 | 27.451 | 47.104 | 56.016 | 58.582 |
| Receivables | - | 369 | 5.373 | 8.196 | 8.526 | 11.464 | 15.468 | 25.874 | 23.334 | 21.394 |
| Cash | - | 10.144 | 293 | 168 | 3.187 | 1.811 | 4.262 | 25.743 | 21.423 | 36.012 |
| Shareholders Funds | - | -5.788 | -19.958 | -15.415 | -8.444 | 7.952 | 37.269 | 93.343 | 149.226 | 126.625 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 16.964 | 38.816 | 34.104 | 31.660 | 27.360 | 8.765 | 11.338 | 15.425 | 78.659 |
| Income in Advance | - | 0 | 8.693 | 6.869 | 5.105 | 3.407 | 1.766 | 201 | 3.100 | 2.278 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Pharma Oas S.r.l.